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Summary
Objective: There is debate whether hyaluronan (HA) can be enzymatically degraded within the extracellular matrix of cartilage and other tis-
sues or whether its catabolism occurs strictly within the lysosomal compartment of chondrocytes and other cell types. Previous studies have
suggested that one of the lysosomal hyaluronidases (hyaluronidase-2) can be expressed as a functionally-active glycosyl phosphatidylinositol-
linked protein at the surface of mammalian cells. If this form of hyaluronidase expression occurs in chondrocytes, this could represent a
possible mechanism for extracellular HA cleavage. Thus, which hyaluronidases are expressed and where was the objective of this study.
Methods: mRNA for hyaluronidases was quantiﬁed by reverse transcription-polymerase chain reaction (RT-PCR) and enzymatic activity by
HA zymograms. Recombinant forms of hyaluronidase-2 were generated and expressed in model cell lines. A peptide-speciﬁc polyclonal an-
tiserum was prepared to localize endogenous human hyaluronidase-2 in human articular chondrocytes.
Results: Hyaluronidase-2 is the principal mRNA transcript expressed by primary human articular chondrocytes as well as various model cell
lines. Recombinant hyaluronidase-2, containing N-terminal or C-terminal epitope tags, was strictly localized intracellularly and not released by
treatment with a phosphatidylinositol-speciﬁc phospholipase. Endogenous hyaluronidase-2 expressed by human chondrocytes as well as
HeLa cells could only be detected following detergent permeabilization of the plasma membranes.
Conclusions: These data suggest that on chondrocytes and other cell types examined, hyaluronidase-2 is not present or functional at the
external plasma membrane. Thus, local turnover of HA is dependent on receptor-mediated endocytosis and delivery to low pH intracellular
organelles for its complete degradation.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Hyaluronan (HA) is a high molecular mass non-sulfated
polymer composed of repeating disaccharide units of
N-acetylglucosamine and glucuronic acid1. It is a major
component of the extracellular matrix and plays an impor-
tant role in matrix assembly, wound healing and embryonic
development2. In addition to potential free radical-mediated
degradation3,4, HA catabolism depends on the enzymatic
activity of hyaluronidases, a family of degradative endoglu-
cosaminidase enzymes with an exclusive speciﬁcity for the
b-1,4-glycosidic bonds between glucuronic acid and
N-acetylglucosamine5.
Six human hyaluronidase-like genes have been identiﬁed
and occur in clusters of three at two chromosomal loca-
tions6. HYAL-1, HYAL-2 and HYAL-3 are located on chro-
mosome 3p21.3 while SPAM-1 (also known as PH-20),
HYAL-4 and HYALP1 are located on chromosome 7q31.3.
In addition, meningioma-expressed antigen 5 (MGEA5)
located on chromosome 10 was shown to be a hyaluroni-
dase as well as an N-acetylglucosaminidase7,8. All the
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HYALP1 are capable of degrading HA6.
HYAL-1 is present in many tissues but is predominantly
found in the plasma and urine6,9,10, has an optimum pH of
3.8 and cleaves HA to small molecular mass fragments
less than 20 kDa11. Transcripts for HYAL-3 have been
detected in brain, liver, bone marrow and cartilage but little
is known about HYAL-3 protein or enzymatic activity9,10,12.
PH-20 was identiﬁed as a glycosyl phophatidylinositol
(GPI)-linked sperm acrosomal enzyme with a neutral
pH optimum that cleaves HA into fragments of less
than 20 kDa13,14. PH-20 mRNA has been shown to be
expressed by chondrocytes, synoviocytes and ﬁbroblasts
but its functional role has not been established15. MGEA5,
found in meningioma patients, is also a neutral pH optimum
hyaluronidase7.
Another prominent hyaluronidase expressed in many tis-
sues including cartilage is HYAL-29,12,16. It has a unique
substrate speciﬁcity in that it hydrolyzes high molecular
mass HA into intermediate-sized fragments of about
20 kDa, has an optimum pH of 4.0, and is localized predom-
inately in lysosomes17. However, recent reports have also
indicated that HYAL-2 may be anchored by a GPI-anchor
to the plasma membrane18,19, exhibit a broad pH activity
spectrum and thus have the capacity to affect the extracel-
lular degradation of HA20. In Xenopus laevis, a HYAL-
2-type hyaluronidase exists both intracellularly as well as
being attached to the cell surface through a GPI-anchor21.49
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but also under physiological conditions, albeit at a slower
rate.
In cartilage, HA turnover occurs locally at the cellular
level22. Chondrocytes internalize HA by way of a CD44-
mediated mechanism, delivering the HA to lysosomes for
its complete degradation23. As shown in the present study
and others12,16, of the three hyaluronidases species,
HYAL-2 is the predominant mRNA transcript expressed
by chondrocytes. Recent evidence suggests that hyaluron-
idase is up-regulated in both osteoarthritis and rheumatoid
arthritis and may partly account for the reduction in the
concentration and size of HA observed in these disease
conditions24. It has been suggested that HYAL-1 and
HYAL-2 may work in concert to degrade HA9. For example,
it has been suggested that there may be an initial cleavage
of HA at the cell surface or within unique acidic endocytic
vesicles by a GPI-linked HYAL-225. These fragments would
then be transported to the lysosomes for further digestion
by HYAL-126. Since chondrocytes express HYAL-1 and
HYAL-2, our interest was to determine whether these cells
utilize a similar two-step pathway for the degradation of HA
and to determine whether this pathway is applicable to other
cell types. In this paper, we investigated the expression and
localization of both endogenous and recombinant HYAL-2
in chondrocytes and a number of other model cell types.
Materials and methods
CELL CULTURE
Chick embryo chondrocytes were isolated from 12-day-
old tibiae by sequential enzymatic digestion of trypsin
(Sigma, St. Louis, MO) followed by collagenase (Roche,
Mannheim, Germany)27. Human articular chondrocytes
were isolated from the normal talocrural ankle joint of
human donors (obtained from the Gift of Hope Organ and
Tissue Donor Network with consent and IRB Institutional
approval). Full thickness articular cartilage slices were
dissected under aseptic conditions and then subjected to
sequential pronase/collagenase (Calbiochem, San Diego,
CA and Boehringer Manheim, Indianapolis, IN, respec-
tively) digestion to liberate chondrocytes as described pre-
viously28. Human and chick primary chondrocytes as well
as HeLa, COS-7 and human embryonic kidney (HEK-293)
cell lines (ATCC ) were all cultured in Dulbecco’s modiﬁed
Eagles medium (DMEM, Gibco-BRL, Grand Island, NY)
with 10% fetal bovine serum (FBS, Summit Biotechnology,
Ft. Collins, CO). The immortalized human chondrocytes cell
line (C-28/I2) was maintained in a 1:1 mixture of DMEM/
Ham’s F12 medium containing 10% FBS. All cells were
maintained in a 5% CO2 humidiﬁed incubator at 37(C.
GENERATION OF THE HYAL-2 CONSTRUCTS
The full length coding region of human HYAL-2 was
obtained by reverse transcription-polymerase chain reaction
(RT-PCR) ampliﬁcation of human chondrocyte total RNA,
using Platinum Pfx DNA polymerase. The ampliﬁcation
primers were engineered to include EcoRI and NotI restric-
tion sites for cloning into expression plasmids. Human
HYAL-2 cDNA was cloned into a green ﬂuorescence protein
(GFP) containing pTracer-EF/V5-His vector (Invitrogen,
Carlsbad, CA) in the sense orientation and into pcDNA 3.1
() (Invitrogen) in the reverse sense orientation. To intro-
duce an myc tag at the N-terminus, the human HYAL-2
cDNA was cloned into a pSecTag2 vector (Invitrogen), using
primers engineered with BamHI and EcoRI restriction sites.TRANSFECTION OF CELLS
To optimize transfection efﬁciency, cells were released
with trypsin (0.25% trypsin, Gibco-BRL) and re-plated one
day prior to transfection. Chick embryonic chondrocytes
were transfected with HYAL-2 containing plasmid in the
presence FuGene 6 (Roche), HeLa cells transfected using
HeLa MONSTER (Mirus, Madison, WI), and COS-7 cells
using Lipofectamine 2000 (Invitrogen), all according to
manufacturers’ directions. In some experiments, 24 h
post-transfection the cells were subsequently transfected
a second time with morpholino antisense oligonucleotides
(50-GTGTCACCTGCCTGGCACCAGCTCA-30, Gene Tools,
Philomath, OR) using Endo-Porter reagent (Gene Tools)
according to manufacturer’s directions to knockdown gene
expression. In other experiments, transfected cells were
subsequently treated with a phosphatidylinositol-speciﬁc
phospholipase C (PI-PLC); 1 unit/ml of PI-PLC in 10 mM
Tris, pH 7.4, containing 144 mM NaCl and 0.05% bovine
serum albumin (BSA). At various time points, the enzyme-
containing cell supernatants were collected and the remain-
ing cell layers extracted for Western blot analysis or
RT-PCR as described below. As a positive control, chon-
drocytes were treated under similar conditions and probed
with an anti-MT4-MMP antibody (Sigma, St. Louis, MO).
MT4-MMP is a known GPI-linked protein that is expressed
by chondrocyte29.
RT-PCR
Total cytoplasmic RNA was extracted frommonolayer cul-
tures of primary human chondrocytes, C-28/I2 cells, HeLa
cells, COS-7 cells and HEK-293 cells using Trizol reagent,
puriﬁed and then subjected to RT-PCR analysis as de-
scribed previously30. The ampliﬁed products were analyzed
by electrophoresis on 1.5% agarose gels followed by stain-
ing with ethidium bromide. The stained products were
scanned and quantiﬁed using a Fluor-S MultiImager ﬂuor-
imaging system with Quantity One 4.1.1 software (Bio-Rad,
Hercules, CA). The primer sequences were HYAL-1:
sense 50-CCAGAATGCCAGCCTGA TGCC-30, antisense
50-GTCATTTTGGGCACGGATGCC-30; HYAL-2: sense 50-
GGCACAATATGAGTT TGAGTTCGC-30, antisense 50-
TTGAGGTACTGGCAGGTCTCCG-30; and HYAL-3: sense
50-CATTTTCTACAAGAACCAACTCGGCC-30, antisense 50 -
CCAATGCAGTTGAGTGT TGCGG-30. These same primer
pairs were also used for quantitative real time RT-PCR.
Thermal cycling and ﬂuorescence detection was performed
in the Smart Cycler system (Cepheid, Sunnyvale, CA) and
PCR products were detected by SYBR Green I Nucleic
Acid Gel Stain (Molecular Probes, Inc., Eugene, OR).
POLYCLONAL RABBIT ANTI-HUMAN HYAL-2 ANTISERA
For the preparation of polyclonal rabbit anti-human
HYAL-2 antisera, a speciﬁc synthetic peptide (11 amino
acids unique for the human HYAL-2 sequence, GDAGYTT-
STET) was prepared by NeoMPS (San Diego, CA). The
puriﬁed peptide was coupled through the terminal cysteine
thiol to Keyhole Limpet Hemocyanin using the heterofunc-
tional cross-linking agent maleimidobenzoyl-N-hydroxysuc-
cinimide ester. The antigen was suspended in phosphate
buffered saline (PBS), emulsiﬁed by mixing with an equal
volume of Complete Freund’s Adjuvant and injected into
the subcutaneous dorsal sites for primary immunization.
Subsequent immunizations were performed using Incomplete
Freund’s Adjuvant. The animals were bleed, the crude serum
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determined by enzyme-linked immunosorbent assay. Aliquots
of antisera from each rabbit were then tested by Western
blotting of lysates derived from human articular chondrocytes.
WESTERN BLOT ANALYSIS
At indicated times, conditioned media were isolated and
concentrated by lyophilization while the cell layers were ex-
tracted for 1 h on ice with 1% Triton X-100 containing
100 mM Tris, pH 7.4, 0.15 M NaCl and 1 protease inhibitor
cocktail (Sigma). The lysates were then cleared by centrifu-
gation at 10,000 g for 10 min and the supernatants were
recovered. The cell lysates and conditioned media were
separated by a 10% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE)31 and electroblotted onto
nitrocellulose membranes. The nitrocellulose membranes
were blocked with 5% nonfat dry milk in PBS containing
0.05% Tween 20 for 1 h, followed by 1 h incubation with
the appropriate primary mouse monoclonal antibody (anti-
V5 antibody at 1:5000, anti-myc antibody at 1:5000) or 3 h
with rabbit anti-human HYAL-2 at 1:120. The blots were
then washed extensively before detection using the Vecta-
stain Elite ABC peroxidase kit (Vector Laboratories, Burlin-
game, CA) and developed using the enzyme substrate
diaminobenzidine tetrahydrochloride. As controls, blots
were probed with the appropriate secondary antibody alone
followed by color development. The bands were imaged
using the Fluor-S ﬂuorimaging systems.
IMMUNOFLUORESCENCE MICROSCOPY
Cells were ﬁxed in 1% paraformaldehyde in PBS, pH 7.0,
for 5 min, washed and then permeabilized with 0.2% Triton
in PBS for 5 min. The cells were washed again and then
blocked in 1% BSA in PBS for 1 h. In some instances, the
permeabilization step was omitted to selectively detect ex-
tracellular HYAL-2 expression. Following blocking, the cells
were incubated with either anti-V5 or anti-myc antibody for
1 h, washed and incubated with ﬂuorescent secondary
anti-mouse antibody, Cy3-conjugated Afﬁpure goat anti-
mouse IgG (1:3000, Jackson ImmunoResearch, West
Grove, PA), for 40 min. With the rabbit anti-human HYAL-
2 antisera, the cells were incubated overnight with the
primary antibody, washed and incubated with goat anti-rabbit
biotinylated secondary antibody for 1 h in PBS containing
3% goat serum. Following extensive washing, the cells
were incubated with 1 mg/ml neutravidin Texas Red (Molec-
ular Probes, Inc., Eugene, OR) in PBS with 1% BSA for
30 min. The cells were then washed, mounted in mounting
media containing the nuclear stain, 40,6-diamidino-2-
phenylindole dihydrochloride (DAPI; Molecular Probes),
and visualized using a Nikon Eclipse E600 microscope
equipped with Y-Fl Epi-ﬂuorescence (Melville, NY), a 60
1.4 n.a. oil-immersion objective and Rhodamine Red
(red), FITC (green) and DAPI (blue) ﬁlters. Images were
captured digitally in real time using a Spot-RT camera
(Diagnostic Instruments, SterlingHeights,MI) andprocessed
using MetaView imaging software (Universal Imaging, West
Chester, PA).
HA ZYMOGRAPHY
Hyaluronidase activity in cell lysates and conditioned
media from embryonic chondrocytes were assayed by HA
zymography as previously described32. Brieﬂy, the samples
were separated on a10%SDSpolyacrylamide gel containing0.17 mg/ml HA (Genzyme, Framingham, MA) followed by
a 1 h incubation in 0.3% Triton X-100 and then overnight
incubation at 37(C in 0.1 M sodium formate, pH 3.7, contain-
ing 0.15 M NaCl. After the overnight incubation, the gel was
treated for 1 h with 1 mg/ml pronase in 20 mM Tris HCl,
pH 8.0 and then stained with 0.5% Alcian Blue in 3% acetic
acid for 30 min. The gel was next destainedwith 40%ethanol
in 3% acetic acid until the background was sufﬁciently re-
duced to visualize the bands. The bands were imaged using
the Fluor-S MultiImaging system.
Results
ENDOGENOUS EXPRESSION OF HYALURONIDASES
IN CULTURED CELLS
Semi-quantitative RT-PCR was used as an initial screen
to determine the relative expression of HYAL-1, HYAL-2
and HYAL-3 mRNA in chondrocytes as well as a variety
of cultured cells that we use as model systems. As shown
in Fig. 1, HeLa cells, COS-7 cells and human articular
chondrocytes each expressed mRNA for all three hyaluron-
idases. The immortalized human chondrocytes cell line
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Fig. 1. Several cell types express HYAL-2 mRNA as the principal
endogenous lysosomal hyaluronidase transcript. Replicate aliquots
of total RNA isolated from (A) HeLa; (B) COS-7; (C) C-28/I2; (D)
HEK-293 cells; or (E and F) primary human articular chondrocytes
were subjected to RT-PCR using primers speciﬁc for human HYAL-1,
HYAL-2 and HYAL-3. Panel F depicts a real time RT-PCR proﬁle
(SYBR-green ﬂuorescence vs cycle number); red line trace ¼
HYAL-2; blue line trace¼HYAL-1; yellow line trace¼HYAL-3.
852 G. Chow et al.: Cellular localization of HYAL-2(C-28/I2) and human embryonic kidney cells (HEK-293)
both expressed HYAL-2 and HYAL-3 but no detectable
HYAL-1. In all of the cultured cells tested, HYAL-2 was
the predominant transcript. The real time RT-PCR results
shown in Fig. 1(F) indicate that differences in the relative
expression of HYAL-1, HYAL-2 and HYAL-3 by human
articular chondrocytes are also observed at low cycle num-
ber. These results supported our continued focus of attention
on the expression and cellular localization of HYAL-2.
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Fig. 2. Recombinant human HYAL-2 mRNA is expressed in cul-
tured cells following transient transfection. Replicate aliquots of to-
tal RNA were isolated from (A) embryonic chick chondrocytes; (B)
HeLa; and (C) COS-7 cells and subjected to RT-PCR to detect
the expression of HYAL-2 mRNA. Lane 1: control, untreated cells;
lane 2: cells transfected with empty pTracer-V5His vector; lane 3:
cultured cells V5-HYAL-2 plasmid alone; or lane 4: co-transfected
together with a reverse-orientation (antisense) full-length HYAL-2
containing plasmid.EXPRESSION OF RECOMBINANT HUMAN HYAL-2
IN CULTURED CELLS
Embryonic chick tibial chondrocytes were used as a chon-
drocyte model system because of their high transfection
efﬁciency. These cells were transfected with a full-length,
human HYAL-2 construct containing a V5-epitope tag at
the C-terminus. Examination of cells for GFP ﬂuorescence
demonstrated that greater than 50% of the cells were suc-
cessfully transfected (data not shown). RT-PCR analysis
documented the expression of recombinant human HYAL-
2 mRNA [Fig. 2(A), lane 3]. No detectable expression of
endogenous chick hyaluronidase was observed in untreated
control cells or empty vector-transfected cells using this
primer pair [Fig. 2(A), lanes 1 and 2, respectively]. Expres-
sion of the recombinant HYAL-2 was also conﬁrmed in
transfected HeLa and COS-7 [Fig. 2(B and C), lane 3, re-
spectively]. In these instances, expression of endogenous
HYAL-2 was observed in control cells [Fig. 2(B and C), lanes
1 and 2] but at substantially lower levels as compared to the
transfected cells. Next, the HeLa and COS-7 cell cultures
were co-transfected with the full-length HYAL-2 together
with a full-length HYAL-2 cloned in the reverse antisense
orientation [Fig. 2(B and C), lane 4]. In both cell types,
HYAL-2 mRNA expression was reduced by approximately
50%.
To assess the expression of recombinant HYAL-2 at
the protein level, cell lysate and medium fractions were
probed with an antibody directed against the V5-epitope
tag. Western blot analysis of cell lysates from chick chon-
drocytes transfected with the human HYAL-2 construct re-
vealed four closely spaced bands in the expected
molecular mass range of HYAL-2 between 50 and 60 kDaStd
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Fig. 3. Recombinant human HYAL-2 is expressed as protein in embryonic chick chondrocytes and HeLa cells. Cell lysates and media fractions
were obtained from (A, B) embryonic chick chondrocytes and (C) HeLa cells, following transfection of these cells with a plasmid containing
human HYAL-2 with a C-terminal V5-epitope tag generating a fusion protein. In panel A, the ﬁrst four lanes represent cell lysates and second
four lanes correspond to concentrated conditioned media. Secondary antibody alone control blots are shown in panel B using lysate (L) or
medium (M) from embryonic chick chondrocytes transfected with V5-HYAL-2 plasmid. Controls also include untreated control cells (lane
labeled C) and cells transfected with empty pTracer-V5His vector (lanes labeled V). Experimental conditions include cells transfected with
V5-HYAL-2 plasmid alone (lanes labeled 1), cells co-transfected together with a reverse-orientation (antisense) full-length HYAL-2 containing
plasmid (lanes labeled 2) and cells subsequently transfected with HYAL-2 antisense morpholino oligonucleotides (lanes labeled 3). Std,
molecular mass standard proteins.
853Osteoarthritis and Cartilage Vol. 14, No. 9[Fig. 3(A), lane 1]. The multiple bands could be due to differ-
ential glycosylation of the protein or the processing of signal
peptides. No bands were detected in the cell lysate of con-
trol cells transfected with the empty vector alone [Fig. 3(A),
lane V]. The recombinant HYAL-2 appears to be primarily
retained in the cell as only faint bands were discernable in
the concentrated media fractions [Fig. 3(A), Media lane 1].
This is not due to a fault in detection as we readily observe
V5-HYAL-1 in medium fractions of HEK-293 cells (data not
shown). No nonspeciﬁc protein bands were detected using
the secondary antibody alone [Fig. 3(B)]. The identity of the
recombinant HYAL-2 protein was further supported by
a subsequent transfection of chick chondrocytes with full-
length HYAL-2 construct together with a HYAL-2 speciﬁc
morpholino antisense oligonucleotide or, co-transfection
with the full-length HYAL-2 construct cloned in the reverse,
antisense orientation. Both of these treatments resulted in
the inhibition of the four HYAL-2 protein bands present in
the chick cell lysates [Fig. 3(A), lanes 2 and 3] and medium
fractions [Fig. 3(A), Media lanes 2 and 3]. Transiently trans-
fected HeLa cells also exhibited three to four positive bands
for human HYAL-2 containing the V5-epitope tag in the
range of 50e60 kDa [Fig. 3(C), lane 1]. Like the embryonic
chick chondrocytes, no nonspeciﬁc background bands were
1 2 3 4
50-
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Fig. 4. Recombinant human HYAL-2 expressed in embryonic chick
chondrocytes is enzymatically active. Following transfection of em-
bryonic chick chondrocytes with V5-HYAL-2 plasmid, cell lysates
were isolated and analyzed by HA zymography. Lane 1: cells trans-
fected with empty pTracer-V5His vector alone; lane 2: cells trans-
fected with V5-HYAL-2 plasmid alone; lane 3: cells co-transfected
with V5-HYAL-2 together with a reverse-orientation (antisense)
full-length HYAL-2 containing plasmid; lane 4: cells transfected
with V5-HYAL-2 followed by subsequent transfection with HYAL-2
antisense morpholino oligonucleotides. Clear bands on a darkened
background depict areas of hyaluronidase activity in which Alcian
blue stainable HA has been degraded and released from the gel.observed in negative control cells [Fig. 3(C), lanes C and V]
and HYAL-2 protein expression was substantially inhibited
by subsequent transfection of the HeLa cells with HYAL-2
morpholino antisense oligonucleotides [Fig. 3(C), lane 2].
HYALURONIDASE ACTIVITY
To determine that the expressed recombinant HYAL-2
protein was functional, HA zymography was performed on
embryonic chick chondrocyte lysates. As shown in Fig. 4,
a small but detectable level of endogenous chick hyaluron-
idase activity was detected (lane 1). However, upon
transient transfection of cells with the full-length human
HYAL-2 construct, the hyaluronidase band intensity was
substantially increased (lane 2). This increased enzymatic
activity was reduced to control levels following transfection
of the cells with the HYAL-2 morpholino antisense oligonu-
cleotide (lane 3) or the antisense HYAL-2 construct (lane 4).
The expression of recombinant human HYAL-2 protein
was also conﬁrmed by immunoﬂuorescence staining of
transfected chick chondrocytes. As shown in Fig. 5, the
recombinant HYAL-2 protein appeared localized within in-
tracellular vesicles (indicated by red ﬂuorescence). As
shown in the three-color overlay image [Fig. 5(B)],
V5-tagged HYAL-2 expression was only observed in GFP-
positive cells and was predominately perinuclear (nuclei
depicted by blue ﬂuorescence DAPI staining). Given that
the C-terminal V5-epitope tag remains associated with the
full-length recombinant HYAL-2 as a fusion protein
(Fig. 3), that is enzymatically functional (Fig. 4) and, local-
ized within vesicular-like organelles (Fig. 5), these results
would suggest that HYAL-2 is not being transferred to
a GPI-linkage. If transfer to a GPI-linkage had occurred,
the V5-epitope tag would have been cleaved off of the
protein. Nonetheless, to decipher whether GPI transfer
was occurring, the human HYAL-2 sequence was next
subcloned into a plasmid expression vector containing an
N-terminal myc-epitope tag.
EXPRESSION OF RECOMBINANT myc-HYAL-2
As shown in Fig. 6(A and B), both HeLa and COS-7 cells
transfected with the myc-tagged HYAL-2 construct exhibited
intense cell-associated red ﬂuorescence for myc-HYAL-2Fig. 5. Transfected embryonic chick chondrocytes accumulate recombinant human HYAL-2 protein intracellularly. Following transient trans-
fection of embryonic chick chondrocytes with V5-HYAL-2 expression plasmid, the cells were immunostained using a monoclonal antibody
directed against the V5-epitope tag followed by a Cy3-conjugated goat anti-mouse secondary antibody (red ﬂuorescence, panel A). Panel
B depicts a three-color digital overlay of the image shown in panel A with DAPI detection of nuclei (blue ﬂuorescence), GFP expression
indicating successfully transfected cells (green ﬂuorescence) and Cy3-positive staining for V5-epitope tag expression (red ﬂuorescence).
Magniﬁcation bar, 10 mm.
854 G. Chow et al.: Cellular localization of HYAL-2Fig. 6. Transfected HeLa and COS-7 cells accumulate c-myc-HYAL-2 protein intracellularly as staining cannot be detected without membrane
permeabilization. HeLa cells (panels A, C and E) and COS-7 cells (panels B, D and F) were transiently transfected with c-myc-HYAL-2 ex-
pression plasmid and then ﬁxed and detergent permeabilized (panels A, B, E and F) or not permeabilized (panels C and D). The cells were
then immunostained using a monoclonal antibody directed against the N-terminal c-myc-epitope tag followed by a Cy3-conjugated goat anti-
mouse secondary antibody. Panel E represents control HeLa cells and panel F, the control COS-7 cells in which the permeabilized cells were
incubated with the secondary Cy3-antibody alone. All images are digital two-color overlays of Cy3-expression (red ﬂuorescence) and DAPI
detection of nuclei (blue ﬂuorescence). Magniﬁcation bars, 10 mm or 20 mm as indicated.but only when the cells were ﬁrst detergent permeabilized
prior to staining. In the absence of permeabilization, condi-
tions that highlight extracellular cell surface staining, no
myc-HYAL-2 was detected [Fig. 6(C and D), respectively].
Further, permeabilization alone is not due to a nonspeciﬁc
ﬂuorescence signal [Fig. 6(E and F), respectively]. These
results indicate that the myc-HYAL-2, like the V5-tagged
HYAL-2, is not present on the cell surface but rather, is
localized intracellularly. Thus, it also appears unlikely
that the myc-HYAL-2 is retained in these cells via a GPI-
linkage.As another approach to address this question, myc-
HYAL-2 transfected HeLa cells as well as transfected
COS-7 cells were treated for various times with a PI-PLC.
PI-PLC is used to cleave GPI-linkages and release proteins
that are retained at the cell membrane via these lipid
anchors18. As shown in Fig. 7, HeLa and COS-7 cells
both exhibited bands for myc-HYAL-2 of w55 kDa in total
cell lysates of transfected cells [Fig. 7(A and B), lane 00,
respectively]. Only faint nonspeciﬁc bands were observed
in untreated control cells [Fig. 7(A and B), lane C] or cells
transfected with empty pSecTag2 vector [Fig. 7(A and B),
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Fig. 7. Recombinant c-myc-HYAL-2 protein expressed by HeLa and COS-7 cells is not depleted by PI-PLC treatment of the cells. Replicate
cultures of HeLa cells (panel A) and COS-7 cells (panel B) transiently transfected with c-myc-HYAL-2 plasmid were then treated with PI-PLC
for varying times and the supernatant media collected (Supernatants). The remaining cells were then washed and extracted with lysis buffer
(Cell Lysates). Controls included nontransfected cells (lane C) and cells transfected with empty pSecTag2 vector (lane V); lanes 00, 300, 600,
1200, c-myc-HYAL-2 transfected cells incubated PI-PLC for 0, 30, 60 or 120 min. Std, molecular mass standard proteins.lane V]. A similar negative reaction staining was observed
in secondary antibody-only control blots (data not shown).
Following 30, 60 or 120 min of treatment of the cells with
PI-PLC, no major reduction in the myc-HYAL-2, associated
with the cell lysates, was observed [Fig. 7(A and B), lanes
300, 600, 1200]. This suggests that the myc-HYAL-2, associ-
ated with either HeLa or COS-7 cells, is not susceptible to
PI-PLC cleavage. Further, no myc-HYAL-2 was detected
in the concentrated supernatant fractions collected follow-
ing PI-PLC treatment of the cells [Fig. 7(A and B), lanes
300, 600, 1200]. Thus, for example, if the small diminution
in HYAL-2 after 30 min of PI-PLC treatment of HeLa cells
[Fig. 7(A)] were due to cleavage at the cell surface, the
released enzyme would have been recovered and detected
in the supernatant fraction [Fig. 7(A), lane Supernatant 300].
Similar results were also observed with myc-HYAL-2 trans-
fected HEK-293 cells (data not shown). As a positivecontrol, MT4-MMP was released into the supernatant frac-
tion when treated with PI-PLC under the same conditions
(data not shown). MT4-MMP is a known GPI-linked protein
that is expressed on chondrocytes29.
GENERATION OF PEPTIDE-SPECIFIC HUMAN HYAL-2
POLYCLONAL ANTISERA AND ITS USE IN DETECTION
OF ENDOGENOUS HYAL-2 PROTEIN
To document the expression and cellular localization of
endogenous HYAL-2 protein, polyclonal antisera were
generated using a peptide sequence speciﬁc to human
HYAL-2. More importantly, the peptide chosen represented
an amino acid sequence not present in any of the other hy-
aluronidases such as HYAL-1 or HYAL-3. Western blot
analysis of cell lysates from human articular chondrocytes
and HeLa cells, using the peptide-speciﬁc HYAL-2 antisera,Std 1 2 3 4 5 6 Std 7 8
50-
kD
35-
HChHEKHCh   HeLa
A
B
50-
kD
1 2 3 4
HeLa HeLa
Fig. 8. Endogenous HYAL-2 protein, expressed by primary human chondrocytes, HeLa and HEK-293 cells, is cell-associated and not released
into the culture media. Panel A: Cell lysates and concentrated media fractions from cultures of primary human chondrocytes, HeLa and HEK-
293 cells were analyzed by Western blot analysis using a rabbit peptide-speciﬁc antisera directed against human HYAL-2. Lanes 1 and 3:
lysates and media derived from primary human chondrocytes, respectively; lanes 2 and 4: lysates and media derived HeLa cells; and lanes
5 and 6: lysates and media derived from HEK-293 cells. In lanes 7 and 8, lysates and media derived human chondrocytes were incubated with
secondary antibody reagents alone as a control. Panel B: Cell lysates from HeLa cells (20 and 40 mg aliquots) were analyzed by both Western
blotting (lanes 1 and 2, respectively) and HA zymography (lanes 3 and 4, respectively). Std, molecular mass standard proteins; HCh, human
chondrocytes; HEK, HEK-293 cells.
856 G. Chow et al.: Cellular localization of HYAL-2revealed a band at w55 kDa [Fig. 8(A), lanes 1 and 2, re-
spectively]. These bands are similar to those observed
with the recombinant V5-HYAL-2 (Fig. 3) or myc-HYAL-2
(Fig. 7). The concentrated conditioned media removed
from these cultures also failed to express detectable levels
of endogenous HYAL-2 [Fig. 8(A), lanes 3 and 4]. This
observation was also supported by Western blot analysis
using endogenous HYAL-2 expressed by HEK-293 cells
[Fig. 8(A), lane 5]. Again, a positive band for HYAL-2 was
only observed in the cell lysate fraction and not in the con-
centrated conditioned medium [Fig. 8(A), lane 6]. Only non-
speciﬁc protein bands were observed in secondary
antibody alone control blots [Fig. 8(A), lanes 7 and 8].
The identity of the bands detected by Western blotting
was also conﬁrmed by HA zymography. Fig. 8(B) depicts
the analysis of 20 and 40 mg aliquots of lysates from
HeLa cells on Western blots (lanes 1 and 2, respectively)
as compared to the same samples analyzed by HA zymo-
graphy (lanes 3 and 4).
Figure 9 depicts the cellular localization of endogenous
HYAL-2 in primary human articular chondrocytes
[Fig. 9(A) and 9A inset] as well as HeLa cells [Fig. 9(C)].
However again, this intense immunoﬂuorescence staining
was only detected following detergent permeabilization of
the cells following ﬁxation. In the absence of membranepermeabilization, no HYAL-2 was detected in either the hu-
man chondrocytes [Fig. 9(B)] or HeLa cells (data not
shown). No immunoﬂuorescent staining was seen with the
secondary antibody alone [Fig. 9(D)]. These data suggest
again that the endogenous HYAL-2 is not localized on the
extracellular face of the plasma membrane of these cell
types.
Discussion
In human, six hyaluronidase-like genes have been identi-
ﬁed with HYAL-1 and HYAL-2 being the most predomi-
nantly expressed gene products in somatic tissues.
HYAL-2 was originally thought to be a lysosomal enzyme
because of its acidic pH optimum17. However, recent stud-
ies have also indicated that HYAL-2 can be found on the
cell surface as a GPI-linked protein as well as a soluble
form18,19,20,33. Thus, it has been proposed that HA degrada-
tion occurs in a stepwise manner whereby HA is ﬁrst
cleaved by cell surface bound HYAL-2 into 20 kDa frag-
ments which are then delivered into lysosomes-like struc-
tures for further degradation by HYAL-1 and two
lysosomal b-exoglycosidases, b-glucuronidase and b-
N-acetylglucosaminidase26.Fig. 9. Endogenous HYAL-2 protein, expressed by primary human chondrocytes or HeLa cells, is localized intracellularly and cannot be de-
tected without membrane permeabilization. Primary human chondrocytes (panel A and inset) and HeLa cells (panel C) were ﬁxed and deter-
gent permeabilized or not permeabilized (panel B). The cells were then immunostained using a rabbit peptide-speciﬁc antisera directed
against human HYAL-2, followed by goat anti-rabbit biotinylated secondary antibody and neutravidin Texas Red (red ﬂuorescence). Panel
D represents control cells in which the permeabilized primary human chondrocytes were incubated with the secondary antibody and biotin
detection reagents alone. All images are digital two-color overlays of neutravidin Texas Red expression (red ﬂuorescence) and DAPI detection
of nuclei (blue ﬂuorescence). Magniﬁcation bars, 10 mm or 20 mm as indicated.
857Osteoarthritis and Cartilage Vol. 14, No. 9In this study, we investigated the expression and localiza-
tion of both endogenous and recombinant HYAL-2 to deter-
mine whether chondrocytes and a number of other model
cell types utilize a similar two-step pathway for the degrada-
tion of HA. Our ﬁndings indicated that both recombinant
C-terminus and N-terminus tagged HYAL-2 were found
localized within intracellular vesicles. Such a similar locali-
zation of epitope tags would not be expected if C-terminal
cleavage had occurred during the transfer of HYAL-2 to
a GPI-anchor. In addition, endogenous HYAL-2 showed
a similar intracellular localization pattern (Fig. 9) which is
in agreement with the recombinant expression data. Further
support for an intracellular localization of the protein came
from (1) the need for the cells to be permeabilized with
detergent before immunoreactivity could be detected
(Figs. 6 and 9) and (2) treatment with PI-PLC did not result
in the reduction in cell-associated HYAL-2 protein (Fig. 7).
Nonetheless, it could be possible that our analytical ap-
proaches were not sensitive enough or appropriate to de-
tect membrane-bound HYAL-2.
These results also conﬁrm our previous observations of
HA turnover in chondrocytes. Addition of puriﬁed 3H-labeled
HA to bovine or rat chondrocytes resulted in the internaliza-
tion ofw5% of the labeled HA probe that was bound at the
extracellular cell surface, within 24 h of incubation23. Analy-
ses of the intracellular pool revealed only two size classes
of label, one that eluted in the void volume of a Sepharose
CL-2B column (i.e., >1 106 Da), and one that eluted in the
total volume of the column (i.e., degradation products of
<50 kDa). Further, the generation of small fragments was
inhibited in the presence of the lysosomotropic agent
chloroquine. The presence of these two pools (i.e., no inter-
mediate sizes) is consistent with a pool of internalized HA
present in endosomes and another, within lysosomes. In
rat keratinocytes, the size of intracellular HA was predomi-
nately <90 kDa25. The generation of these small, exten-
sively degraded products was also inhibited by the
presence of the lysosomotropic agents chloroquine,
NH4Cl or the hyaluronidase inhibitor apigenin. Therefore,
the intracellular degradation of HA occurs within a low pH
environment, such as that of the lysosome. Nonetheless,
these data cannot rule out the possibility that some internal-
ized HA in the degraded fraction could be present in an
acidiﬁed endosome that includes a hyaluronidase activity
such as HYAL-2.
Many GPI-linked proteins have been determined for the
amino acid sequences of their signal peptides, by compar-
ing the matured proteins sequences with that of the nascent
proteins as predicted from their cDNA sequences 34,35. The
signal for GPI-anchor is characterized by a C-terminal hy-
drophobic domain that is preceded by a short hydrophilic
spacer linked to the GPI-anchor attachment site36 which
is replaced during the transfer to the GPI moiety. Amino
acid sequence analysis of HYAL-2 indicates the presence
of such a signal18. However, our study seems to suggest
that the presence of a putative GPI-linkage in the predicted
cDNA sequence does not necessarily translate into a GPI-
anchored protein. This is exempliﬁed by LFA-3 whereby
cDNA-predicted sequence of the precursor form of GPI-
linked protein is the same as the transmembrane form of
the protein suggesting that the fate of a GPI-anchored pro-
tein is not necessarily encoded in the primary RNA tran-
script but is a posttranscriptional event34 and both forms
can be coexpressed in many cell types37. Depending on
the cell type and/or development stage, alternate RNA
processing could also result in other forms of the protein
despite the presence of a putative signal in the cDNAsequence as seen with neural cell adhesion molecule38.
Thus, the cellular localization of HYAL-2 is a complex issue
and it could exist in various forms that might be dependent
on the cell type and/or its developmental state. As such,
HYAL-2 expression extracellularly might occur in some
cell types as a highly transient event or in some way en-
hanced during certain pathological conditions.
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